Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by TMAZZ21on Feb 07, 2023 8:47pm
364 Views
Post# 35273378

Shareholders rights

Shareholders rightsIf there is negotiations happening with Pfizer than wouldn't we as shareholders have the right to know when an offer is presented!

In order to start any kind of negotiations would Pfizer start with an offer.
Then negotiations starts!

If I compare it to buying real estate even commercial real estate. Some one normally comes with an offer first to show interest and then negotiate from there.

From all these posts, it sounds like the normal is to start negotiations then come up with an offer. 

The point I'm trying to make is, if there's an offer on the table and ONC are in negotiations based on an offer from Pfizer
then don't  shareholders have a right to know!

Or does this 90 day code of silence protect the companies of disclosing of any offers and or negotiations!

We don't need to know exactly what the offer is or what the negotiations are about  BUT we should have the right as shareholders to know if Onc was presented with an offer or if there's any negotiations regarding an offer negotiations.
<< Previous
Bullboard Posts
Next >>